Bogus ‘Cure’ Claims Have U.S. Consumers Snapping Up CBD Products
The Pharma Data
OCTOBER 15, 2020
Food and Drug Administration] has only approved CBD for one rare childhood condition for epilepsy,” giving its stamp to a CBD medication called Epidiolex , said study co-author Erik Hendrickson, a research associate at the Center for Data Driven Health at the Qualcomm Institute at the University of California, San Diego.
Let's personalize your content